−£13k
vs Dec 2023Active11725123Private limited companyLondon
GENETIS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Genetis Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Genetis Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GENETIS LIMITED is an active private limited company (company number 11725123) incorporated on 13 December 2018, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£13k and cash of £3,927, with 3 employees on average. Net assets rose 43% on the prior period (−£23k).
Peer position · net assets
By net assets it sits in the bottom quarter of 76 comparable companies in London (median £100, upper quartile £88k).
02
Ownership and control
No active person with significant control is registered.
- Mr Jean Jacques Pierre Chalopin
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 13 December 20187 yrs ago
- Next accounts due
- 30 September 202627 days overdue
- Confirmation statement due
- 27 December 2026in 61 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£3,927
+446%vs Dec 2023Not reported
3
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£13k | £3,927 | — | £17k | — | — | 3 |
| 31 December 2023 | −£23k | £719 | £761 | £24k | — | — | 3 |
Current ratio0.23Current assets ÷ creditors within one year
Cash per employee£1,309Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-12,977 at 31 December 2024
- Net assets up 10% or more on the prior period+43.1% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.23
- Incorporated five or more years agoIncorporated 13 December 2018
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 61 days
- Next accounts due27 days overdue
- Accounts period endNet liabilities £13k · small accounts
- Accounts period endNet liabilities £23k · small accounts
- Incorporated
08
Similar companies in London
- CELADON PHARMA HOLD CO LTDLondon · inc. Jan 2019
- ECLIPSE PHARMA LTDLondon · inc. Feb 2019
- INFIRST LIMITEDLondon · inc. Feb 2019
- SPF EXPERT LTDLondon · inc. Oct 2018
- CELADON PHARMA LTDLondon · inc. Sept 2018
- NAOTA KABAF GLOBAL VENTURES LTDLondon · inc. Apr 2019
All companies incorporated on 13 December 2018 · in Dec 2018.
09
Reminders for GENETIS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.